13th International Conference on Biologics and Biosimilars

Amsterdam, Netherlands | Europe , Netherlands

Event

13th International Conference on Biologics and Biosimilars - Amsterdam, Netherlands
Start Date: 18.03.2019
End Date: 19.03.2019
Type : Conference
From : 300$
Το : 1550$

About conference

 

Biosimilars Conferences is inviting you to attend Biosimilars Congress 2019 on March 18-19, 2019 Amsterdam | Netherlands. The topic of the current year's gathering is Biosimilars & Biologics: Present Scenario & Future Prospects which will give a worldwide stage to talk of present and future of Biosimilars.

Biosimilars Congress 2019 gathering will empower us to continue plunging further into both the examination of Biosimilar change and the business necessities for associations.

The Organizing Committee is satisfied to welcome you to attend the "13th International Conference on Biosimilars and Biologics", one of its astonishing Pharmaceutical gatherings to be held in March 18-19 | 2019 in Amsterdam, Netherlands.

Our Conferences on Biosimilars joins scientists, authorities and CROs from around the world. The Biosimilars Congress 2019 experiences an exponential improvement over the coming couple of years. Various Biologics things are affecting their passage in the pharma to publicize and experiencing a striking climb in their utilization over the standard remedies.

At Biosimilars 2019 meet your planned intrigue bunches from around the world focused on getting some answers concerning Biosimilars and Biologics. This gathering would be your single most obvious opportunity to accomplish the greatest accumulation of individuals from the Biosimilars and Biologics gathering.

Biosimilars Congress 2018 gather was a hit we could get learning from two specific gathering one that surpassed desires in the deliberate and collecting end and one that surpassed desires in the business and key end.

This year’s flagship event will gather top Europe Associations, Societies, Companies, Laboratories, Global regulators, Officials, Healthcare Actors as well as Industry leaders, to foster open exchange and debate on the role of the Biosimilars and Biologics sector in “Biosimilars Congress 2019 : Present Scenario & Future Prospects”.

 

Why to Attend?

 

Biosimilars Congress 2019 gives a complete 360-degree overview on Biosimilars and Biologics: Present scenario & Future prospects. Participants will leave the conference with a wealth of new information and an expanded network of contacts.

The Biosimilar is a lucrative sector owing to recent regulatory approvals and increasing opportunities. Biosimilars and Biologics are at different stages of evolution across the globe. Developing a Biosimilars demands huge investment, technical capabilities and clinical trial expertise. In order to unlock the Biosimilars potential, the industry will entail focused strategies along the whole value chain, from optimizing the clinical development program to commercialization.

Biosimilars Conferences developments are maintaining their momentum and the 2019 Biosimilars Conferencesprogramme delves into strategic discussions regarding:

  • Market and regulatory developments in the Europe and globally, enlightened by the perspective of healthcare professionals and patients experiences
  • Pharmacovigilance and clinical practice - what can be learned from the emerging data?
  • The impact of Biosimilars on the competitive landscape of biological products
  • Developing Biosimilars & Biobetters
  • Innovator Pharmaceutical Products of Biosimilars
  • Current Challenges and Research trends in Biosimilars & Biologics
  • Biosimilars: Pharmacovigilance and Safety
  • BCS & IVIVC Based Biowaivers
  • Biopharmaceutical
  • Biological Medicines
  • Bioequivalence Assessment
  • Developing Biosimilars & Biobetters
  • Generics and Biosimilars: Industrial Strategy
  • Globalization of Biosimilars
  • GMP, GCP, QC & R&D
  • Innovation and Technology for Biosimilar Development
  • Intellectual Property Rights
  • Novel Drug Delivery Technologies
  • Pharmacology and Drug Development
  • Plant Produced Biosimilars
  • Protein Biotherapeutics and Biosimilars
  • Regulatory Approach for Biosimilars

Learning objectives

  • Update the participants on the current knowledge including regulatory and scientific thinking
  • Deal with regulatory requirements, scientific and operational challenges
  • Exchange experiences and discuss hot topics with experts
  • Frame the current issues and create dialogue

Key Features

  • Meet Regulatory Expectations
  • Devise Strategies
  • Explore different statistical approaches to demonstrate Biosimilarity with the reference product
  • Panel Discussion and Extended Q&A Sessions
  • Open forum to discuss your most critical questions around Biosimilars & Biologics
  • National & International Speakers
  • Networking with National and International Industry stalwarts who will inspire, educate and engage in all the aspects of Biosimilars.
  • Gain insights and enhance your knowledge with Biosimilars Congress 2019.
  • Provides interaction with the world's well known CEO's and Directors of the Pharmaceutical companies.

In this limelight, Biosimilars Congress is pleased to announce the “13th International Conference on Biosimilars and Biologics” on March 18-19, 2019 in Amsterdam, Netherlands. This conference will congregate top industry stalwarts to discuss key challenges and best practices from development to launch of Biosimilars and Biologics of market existence

Join your companions the world over focused on getting some answers concerning Biologics and Biosimilarsrelated advances, which is your single most obvious opportunity to accomplish the greatest gathering of individuals from the Biosimilars society, coordinate shows, scatter information, meet with recurring pattern and potential specialists, make a sprinkle with new research works, and get name affirmation at this Two-day event. Broadly acclaimed speakers, the most recent research, moves, and the most momentum refreshes in Biologics and Biosimilars are indications of this gathering. Provision of information on new technologies implemented in the field of Biosimilars and a sound knowledge on the Clinical Trail development.